Key facts
- Flagler Health’s last known valuation is $50.0M (Feb 2025).
- It has raised $11.5M; the latest was Early Stage VC ($8.5M) in Feb 2025.
- Notable investors include MassChallenge, SignalFire, 186 Ventures, Streamlined Ventures Management, Venture Initiation Program.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Flagler Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Flagler Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Flagler Health
Developer of clinical decision support software designed to turn clinics into virtually vertical health systems. The company's platform utilizes patient data and clinical guidelines to identify potentially beneficial procedures that physicians may have overlooked, enabling healthcare providers to deliver more comprehensive care that improves patient outcomes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 44
- Website
- flaglerhealth.io/
- Ownership
- Privately Held (backing)
Flagler Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Flagler Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Flagler Health in its N-PORT filings yet. We sweep new filings monthly.